TCL Archive Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency. December 19, 2008
TCL Archive Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials. December 2, 2005
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block March 18, 1977
